Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Context Asset Management launches macro fund

Thursday, August 28, 2014

Bailey McCann, Opalesque New York:

Context Asset Management has filed for its second fund the Context Macro Opportunities fund, according to SEC filings. The fund will focus on multiple macro strategies including break-even inflation trading, capital structure arbitrage, hedged mortgage-backed securities trading, and volatility spread trading.

Conext launched its first fund in April of this year, that fund - Context Alternative Strategies Fund (CALTX), is a multi-manager, multi-strategy fund. Sub-advisors for CALTX include Highland Capital Management; Phineus Partners; Kellner Capital; Weatherbie Capital; ESM Management; Armory Funds; First Principles Capital Management, and Del Mar.

First Principles Capital Management will be the sub-advisor on the second fund. First Principals is based in New York and Atlanta, with approximately $10 billion in assets under management. The firm focuses primarily on fixed income and derivatives trading.

As with CALTX, the Macro Opportunities fund is a hedged mutual fund. CALTX was most recently made available on the Fidelity, Pershing and Charles Schwab investment platforms.

As a firm, Context Asset Management is relatively new having only been formed in Q1 of this year, but has been successful in attracting assets to the first fund, and now filing the second.

The alternatives mutual fund market is......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its